G protein-coupled receptor kinase 2 modifies the ability of Caenorhabditis elegans to survive oxidative stress.
Aging
Caenorhabditis elegans (C. elegans)
G protein coupled receptor kinase (GRK)
Oxidative stress
Resistance
Stress response
Journal
Cell stress & chaperones
ISSN: 1466-1268
Titre abrégé: Cell Stress Chaperones
Pays: Netherlands
ID NLM: 9610925
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
01
07
2020
accepted:
22
09
2020
revised:
19
09
2020
pubmed:
17
10
2020
medline:
25
12
2021
entrez:
16
10
2020
Statut:
ppublish
Résumé
Survival and adaptation to oxidative stress is important for many organisms, and these occur through the activation of many different signaling pathways. In this report, we showed that Caenorhabditis (C.) elegans G protein-coupled receptor kinases modified the ability of the organism to resist oxidative stress. In acute oxidative stress studies using juglone, loss-of-function grk-2 mutants were more resistant to oxidative stress compared with loss-of-function grk-1 mutants and the wild-type N2 animals. This effect was Ce-AKT-1 dependent, suggesting that Ce-GRK2 adjusted C. elegans oxidative stress resistance through the IGF/insulin-like signaling (IIS) pathway. Treating C. elegans with a GRK2 inhibitor, the selective serotonin reuptake inhibitor paroxetine, resulted in increased acute oxidative stress resistance compared with another selective serotonin reuptake inhibitor, fluoxetine. In chronic oxidative stress studies with paraquat, both grk-1 and grk-2 mutants had longer lifespan compared with the wild-type N2 animals in stress. In summary, this research showed the importance of both GRKs, especially GRK2, in modifying oxidative stress resistance.
Identifiants
pubmed: 33064264
doi: 10.1007/s12192-020-01168-z
pii: 10.1007/s12192-020-01168-z
pmc: PMC7736396
doi:
Substances chimiques
Caenorhabditis elegans Proteins
0
G-Protein-Coupled Receptor Kinase 2
EC 2.7.11.16
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
187-197Références
Redox Biol. 2017 Apr;11:708-714
pubmed: 28193593
J Mol Cell Cardiol. 2015 Dec;89(Pt B):360-4
pubmed: 26506135
J Biol Chem. 2010 Apr 23;285(17):12823-30
pubmed: 20124405
Neuron. 2004 May 27;42(4):581-93
pubmed: 15157420
Circulation. 2000 Aug 15;102(7):793-9
pubmed: 10942749
Am Heart J. 2007 May;153(5):868-73
pubmed: 17452166
J Biol Chem. 2017 Apr 7;292(14):5943-5956
pubmed: 28213524
Curr Biol. 2006 Oct 24;16(20):2042-7
pubmed: 17055984
J Pharmacol Toxicol Methods. 2004 Nov-Dec;50(3):209-14
pubmed: 15519907
Redox Biol. 2015;4:180-3
pubmed: 25588755
J Biol Chem. 1998 Aug 7;273(32):20308-16
pubmed: 9685381
ACS Chem Biol. 2012 Nov 16;7(11):1830-9
pubmed: 22882301
J Biol Chem. 2012 May 18;287(21):17088-99
pubmed: 22467873
Nat Med. 2005 Sep;11(9):952-8
pubmed: 16142243
J Cardiovasc Pharmacol Ther. 2017 Jan;22(1):51-53
pubmed: 27222484
Sci Signal. 2018 Dec 11;11(560):
pubmed: 30538174
Cell Signal. 2016 Mar;28(3):190-203
pubmed: 26631573
WormBook. 2013 Dec 26;:1-43
pubmed: 24395814
Annu Rev Physiol. 2007;69:451-82
pubmed: 17037978
Cancer Res. 2014 Jul 1;74(13):3489-500
pubmed: 24755472
Biochem J. 2017 Jun 27;474(14):2301-2313
pubmed: 28572156
EMBO J. 2009 Sep 16;28(18):2706-18
pubmed: 19661922
Biochem J. 2009 Dec 14;425(1):169-78
pubmed: 19796012
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20479-84
pubmed: 23185015
J Cell Physiol. 2012 Jun;227(6):2371-7
pubmed: 21826651
Proc Natl Acad Sci U S A. 2012 May 1;109(18):7055-60
pubmed: 22509025
Mol Biol Cell. 2013 Sep;24(18):2795-806
pubmed: 23904266
Bio Protoc. 2017 Jan 5;7(1):
pubmed: 29276721
Mol Biol Cell. 2005 Jul;16(7):3088-99
pubmed: 15843435
J Cell Physiol. 2013 Sep;228(9):1897-901
pubmed: 23460259
Front Oncol. 2014 Apr 09;4:75
pubmed: 24782986
J Mol Endocrinol. 2003 Apr;30(2):253-62
pubmed: 12683947
FEBS Lett. 2005 Jan 3;579(1):122-6
pubmed: 15620700
Oncol Rep. 2016 May;35(5):3068-74
pubmed: 26936374
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12457-62
pubmed: 18711143
Biochemistry. 2011 Aug 16;50(32):6933-41
pubmed: 21728385
Cell Cycle. 2009 Jun 1;8(11):1681-7
pubmed: 19411855
Genome Biol. 2001;2(1):RESEARCH0002
pubmed: 11178279
Biomark Med. 2017 Nov;11(11):11031-1040
pubmed: 29039206
PLoS One. 2011;6(8):e23525
pubmed: 21858155
Sci Transl Med. 2015 Mar 4;7(277):277ra31
pubmed: 25739765
J Neurochem. 2008 Feb;104(4):979-92
pubmed: 17971124
Int J Biomed Sci. 2008 Jun;4(2):89-96
pubmed: 23675073
Eur Heart J. 2005 Sep;26(17):1752-8
pubmed: 16055494
Am J Physiol Cell Physiol. 2019 Oct 1;317(4):C674-C686
pubmed: 31268780
EMBO J. 2006 Jan 25;25(2):312-22
pubmed: 16407969
Cardiovasc Psychiatry Neurol. 2009;2009:327360
pubmed: 20204079
WormBook. 2006 Feb 11;:1-11
pubmed: 18050451
PLoS Pathog. 2013;9(10):e1003660
pubmed: 24146615
J Biol Chem. 2007 Jan 12;282(2):1205-15
pubmed: 17102134
Trends Genet. 2013 Jun;29(6):367-74
pubmed: 23428113
J Cell Sci. 2006 Oct 1;119(Pt 19):4088-100
pubmed: 16968739
J Biol Chem. 2006 Nov 10;281(45):34159-70
pubmed: 16980301
Toxicol Sci. 2008 Nov;106(1):5-28
pubmed: 18566021
PLoS One. 2012;7(5):e37831
pubmed: 22629462
Curr Neuropharmacol. 2009 Mar;7(1):65-74
pubmed: 19721819
J Biol Chem. 2000 Aug 25;275(34):26515-22
pubmed: 10852916
J Biol Chem. 2000 Sep 22;275(38):29724-30
pubmed: 10884381
Eur J Pharmacol. 2007 Oct 15;572(1):23-31
pubmed: 17610875
Genes Dev. 2008 Dec 1;22(23):3236-41
pubmed: 19056880
Cell Death Discov. 2018 Feb 14;4:25
pubmed: 29531822
Biochem J. 1993 Jun 1;292 ( Pt 2):605-8
pubmed: 8389142
Front Cardiovasc Med. 2016 Dec 06;3:48
pubmed: 27999776
Cancer Cell. 2008 Dec 9;14(6):427-9
pubmed: 19061832
Mol Cell Biochem. 2019 Nov;461(1-2):103-118
pubmed: 31363957
Psychopharmacology (Berl). 2020 Jan;237(1):127-136
pubmed: 31473777
EBioMedicine. 2016 Nov;13:132-145
pubmed: 27720394
Neurotox Res. 2006 Aug;10(1):43-56
pubmed: 17000469